68Ga-NODAGA-JR11

N/A

Report date: 2025/11/14 09:32:53

Base Information

Drug Name68Ga-NODAGA-JR11

Drug Alias NameN/A

ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Gallium > 68GaRadiation-emitting products > Radionuclide Drug Conjugates

Mechanisms of ActionSomatostatin receptor antagonists

TargetsSomatostatin receptor

Therapy Area/IndicationsNeuroendocrine Tumors

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesFirst Affiliated Hospital Of Fujian Medical University

China Registration ClassN/A

Develop Information

Active CompaniesFirst Affiliated Hospital Of Fujian Medical University

Inactive CompaniesN/A

Active IndicationsNeuroendocrine Tumors

Inactive IndicationsN/A

Other Information

ATC CodeN/A